| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors
|
Stephenson, Joe J.
|
|
2009
|
8 |
1 |
p. 29-37
9 p.
|
article
|
| 2 |
A Study of the MTHFR Gene Polymorphism C677T in Colorectal Cancer
|
Derwinger, Kristoffer
|
|
2009
|
8 |
1 |
p. 43-48
6 p.
|
article
|
| 3 |
Clinical Colorectal Cancer: “2008 – The Year in Review”
|
Chu, Edward
|
|
2009
|
8 |
1 |
p. 9-10
2 p.
|
article
|
| 4 |
Coronary Vasospasm with Myocardial Stunning in a Patient with Colon Cancer Receiving Adjuvant Chemotherapy with FOLFOX Regimen
|
Cerny, Jan
|
|
2009
|
8 |
1 |
p. 55-58
4 p.
|
article
|
| 5 |
Does Celecoxib Have a Role in the Treatment of Patients with Colorectal Cancer?
|
Fakih, Marwan G.
|
|
2009
|
8 |
1 |
p. 11-14
4 p.
|
article
|
| 6 |
Improving Colorectal Cancer Screening and Care in the Veterans Affairs Healthcare System
|
Chao, Herta H.
|
|
2009
|
8 |
1 |
p. 22-28
7 p.
|
article
|
| 7 |
Oxaliplatin-Mediated Autoimmune Thrombocytopenia
|
Saif, Muhammad Wasif
|
|
2009
|
8 |
1 |
p. 61-62
2 p.
|
article
|
| 8 |
Panitumumab Monotherapy in Patients with Metastatic Colorectal Cancer and Cetuximab Infusion Reactions: A Series of Four Case Reports
|
Langerak, Alan
|
|
2009
|
8 |
1 |
p. 49-54
6 p.
|
article
|
| 9 |
Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III
|
Robertson, Jane D.
|
|
2009
|
8 |
1 |
p. 59-60
2 p.
|
article
|
| 10 |
Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
|
Kozuch, Peter
|
|
2009
|
8 |
1 |
p. 38-42
5 p.
|
article
|
| 11 |
Role of Pharmacogenetics as Predictive Biomarkers of Response and/or Toxicity in the Treatment of Colorectal Cancer
|
Bhushan, Shriya
|
|
2009
|
8 |
1 |
p. 15-21
7 p.
|
article
|
Journal description